Tandem Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,690
Closed -$445K 109
2023
Q2
$445K Sell
2,690
-357
-12% -$57.6K 0.29% 75
2023
Q1
$472K Sell
3,047
-15
-0.5% -$2.42K 0.33% 68
2022
Q4
$541K Hold
3,062
0.43% 58
2022
Q3
$517K Buy
3,062
+10
+0.3% +$1.69K 0.44% 60
2022
Q2
$542K Hold
3,052
0.43% 57
2022
Q1
$554K Buy
3,052
+785
+35% +$134K 0.38% 60
2021
Q4
$388K Buy
2,267
+662
+41% +$108K 0.22% 74
2021
Q3
$259K Hold
1,605
0.16% 82
2021
Q2
$264K Sell
1,605
-70
-4% -$11.6K 0.17% 81
2021
Q1
$275K Sell
1,675
-97
-5% -$15.7K 0.19% 76
2020
Q4
$279K Sell
1,772
-290
-14% -$42.8K 0.21% 74
2020
Q3
$307K Buy
2,062
+433
+27% +$64.1K 0.27% 66
2020
Q2
$229K Sell
1,629
-139
-8% -$20.3K 0.22% 71
2020
Q1
$232K Hold
1,768
0.26% 68
2019
Q4
$258K Buy
+1,768
New +$240K 0.22% 69

Other funds holding JNJ

Tandem Capital Management's JNJ Position: Q3 2023 in Review

Tandem Capital Management sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 2,690 shares — an estimated $445K sold.

Tandem Capital Management first reported a position in JNJ in Q4 2019 and held it in 15 quarters. The position peaked at $554K in Q1 2022. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Tandem Capital Management reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • Tandem Capital Management sold 2,690 Johnson & Johnson shares in Q3 2023, an estimated $445K.
  • Tandem Capital Management first reported a position in Johnson & Johnson in Q4 2019 and held it in 15 quarters.
  • Tandem Capital Management's Johnson & Johnson position peaked at $554K in Q1 2022.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Tandem Capital Management's 13F filing for Q3 2023, filed 30 Oct 2023.